JCM | Free Full-Text | Aging with Down Syndrome—Where Are We Now and Where Are We Going?
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial - The Lancet
Alzheimer Disease in Down Syndrome: Overview, Pathophysiology/Risk Factors, Epidemiology
Cureus | Treatment Modalities for Dementia in Down's Syndrome: A Literature Review | Article
Molecules | Free Full-Text | Pharmacological Approaches to the Treatment of Dementia in Down Syndrome: A Systematic Review of Randomized Clinical Studies
Strongest evidence yet to support the treatment of dementia in people with Down syndrome using standard dementia medication | UCL News - UCL – University College London
Erkrankungen von Menschen mit Trisomie 21 im mittleren und höheren Lebensalter
Down syndrome - Wikipedia
Maßgeschneiderte Pharmakotherapie
SID 178103212 - PubChem
Donepezil: Wirkung und Gegenanzeigen - Besser Gesund Leben
Dementia in Down's syndrome - The Lancet Neurology
JCM | Free Full-Text | Aging with Down Syndrome—Where Are We Now and Where Are We Going?
Alzheimer's disease associated with Down syndrome: a genetic form of dementia - The Lancet Neurology
What is Down Syndrome? Symptoms, Causes, Diagnosis & Physiotherapy Treatment of Down Syndrome......
Die organischen Facetten des Down-Syndroms
Caring for Patients With Down Syndrome - Dimensions of Dental Hygiene | Magazine
Japan's Eisai to start Down's syndrome therapy test
Maßgeschneiderte Pharmakotherapie
Donepezil 10mg #28t - Aversi
Maßgeschneiderte Pharmakotherapie
State‐of‐the‐art therapy for Down syndrome - Lorenzon - Developmental Medicine & Child Neurology - Wiley Online Library
State‐of‐the‐art therapy for Down syndrome - Lorenzon - Developmental Medicine & Child Neurology - Wiley Online Library
Erkrankungen von Menschen mit Trisomie 21 im mittleren und höheren Lebensalter
Erkrankungen von Menschen mit Trisomie 21 im mittleren und höheren Lebensalter
